PUBLISHER: Verified Market Research | PRODUCT CODE: 1626553
PUBLISHER: Verified Market Research | PRODUCT CODE: 1626553
Increasing stress, poor diet, hormonal imbalances, and an increase in occurrences of androgenetic alopecia are all contributing to the market's growth. Consumers are becoming more conscious of their personal grooming and aesthetics. With a greater emphasis on young appearance, both men and women are looking for effective ways to counteract hair thinning and balding is fuelling the USD 23.4 Billion in 2024 and reaching USD 63.4 Billion by 2031.
Technological improvements such as laser therapy and hair growth serums, together with increased availability of over-the-counter products, are driving market expansion. Furthermore, the influence of social media and celebrity endorsements of hair care products has raised consumer interest, transforming hair loss therapy into a thriving sector globally is grow at a CAGR of about 13.26% from 2024 to 2031.
Hair Loss Treatment Products Market: Definition/ Overview
Hair loss therapy goods include drugs, topical treatments, shampoos, serums, and gadgets that aim to delay, prevent, or reverse hair thinning and balding. These products are often used to treat androgenetic alopecia, hormonal hair loss, and environmental hair damage. Applications include increasing hair regrowth, strengthening existing hair, and preventing further hair loss, and are popular with both men and women. This market's future looks good, owing to advances in biotechnology, individualized treatments, and rising customer demand for non-invasive remedies. Innovations such as stem cell therapy and enhanced hair growth formulas are projected to fuel future market growth.
The global laser therapy segment of the hair loss treatment market is rapidly expanding, with laser-based solutions emerging as a popular non-invasive treatment option. According to Market Watch data from February 2024, the laser therapy market generated USD 3.1 Billion in 2023 and is expected to rise at a CAGR of 15.6% through 2028. In January 2024, the FDA approved upgraded at-home laser therapy equipment, which resulted in a 92% rise in consumer acceptance rates. In March 2024 Recent clinical trials published in the International Journal of Trichology found that low-level laser therapy (LLLT) resulted in successful hair regeneration in 85% of participants over a six-month period, with particular efficacy among patients aged 25-45.
Philips will released their groundbreaking AI-powered laser therapy hat in December 2023, with clinical testing showing a 67% improvement in hair density. HairMax, a world leader in laser devices, announced in February 2024 a strategic alliance with Chinese healthcare company BeiGene to deliver its latest laser band technology throughout Asia, backed by a USD 150 Million investment. In March 2024, the European Medicines Agency (EMA) approved a new combination therapy combining laser treatment with growth factors, while in April 2024 the Australian government set aside AUD 75 million for research into enhanced laser technology for hair restoration. Furthermore, Venus Concept's quarterly report in March 2024 disclosed a 178% rise in laser device sales compared to the previous year, demonstrating the expanding consumer
High product costs and uneven performance can seriously impede the expansion of the hair loss treatment products market. Many treatments, particularly those requiring a prescription or involving advanced therapies such as stem cell treatments, are expensive. This can limit access to a larger consumer base, especially in emerging economies with smaller disposable expenditures. Furthermore, the financial burden involved with continued therapies may prevent customers from pursuing remedies entirely, resulting in lower market demand. For example, while some consumers may be prepared to pay in successful hair loss solutions, uncertainty about the results may lead to caution in spending, especially for those who have previously encountered disappointment with less effective items.
Furthermore, the uneven efficacy of hair loss therapies might lead to consumer distrust and unhappiness. Many medicines on the market, including topical therapies like as minoxidil and finasteride, may not guarantee results for everyone, resulting in diverse user experiences. The lack of a common remedy for all types of hair loss complicates matters further, as individual therapy responses can vary depending on genetic, hormonal, and lifestyle variables. This discrepancy may lead to a loss of trust in the market, forcing potential clients to seek alternate cures or avoid therapy entirely. As a result, producers confront the problem of not only manufacturing good products but also building reputation and confidence among consumers.
Shampoos and conditioners are widely used in regular hair care routines, which might greatly boost the market for hair loss treatment solutions. As people become more aware of the importance of scalp health and hair maintenance, they are incorporating specialist hair care products that address hair loss into their regular routines. For example, manufacturers like as Nioxin and Kerastase are introducing shampoos and conditioners that are particularly designed to strengthen hair and stimulate growth while also addressing thinning hair concerns. In May 2024 L'Oreal launched plant-based hair care products to improve scalp health and meet the growing demand for eco-friendly choices. This emphasis on preventive care is causing more people to seek items that not only clean and condition hair but also contribute to overall hair health.
In April 2024, the FDA announced its support for clinical research on new formulations that combine traditional hair care products with active hair restoration chemicals, with the goal of increasing their effectiveness. This regulatory backing is anticipated to increase consumer trust in using these products on a regular basis, as they are intended not only for cosmetic appeal but also for genuine hair growth benefits.
However, the serum segment is the fastest expanding, owing to increased demand for focused therapies with greater efficacy and faster outcomes. Hair growth serums, which are frequently loaded with modern compounds such as peptides and minoxidil, are gaining popularity among consumers looking for more effective, non-invasive treatments for hair thinning and regrowth.
Rising sales through pharmacies are expected to greatly boost the hair loss treatment products industry. Pharmacies are increasingly becoming favored distribution channels for hair loss treatments due to their accessibility and consumers' trust in them for health-care items. The simplicity of purchasing hair loss remedies alongside other personal care items appeals to consumers looking for discreet and uncomplicated answers to their hair problems. Recent agreements between pharmaceutical firms and retail chains aim to increase the availability of popular therapies such as minoxidil and finasteride, allowing consumers to obtain effective remedies more easily. For instance, in June 2024, Walgreens announced a collaboration with numerous producers to ensure that popular hair loss remedies are more prominently advertised in their shops, thus catering to rising consumer demand.
In February 2024, the United States Department of Health initiated a campaign to educate the public on hair health, including the availability of treatments at local pharmacies. This campaign is aimed to raise awareness and encourage customers to seek out drugstore remedies for hair loss. With pharmacies serving as trustworthy sources of health information, this effort attempts to increase consumer confidence in purchasing hair loss remedies.
However, the fastest expanding area is online retail, which is driven by the convenience of home delivery, a larger selection of product offerings, and rising consumer preference for e-commerce platforms. Discounts, user reviews, and focused marketing all help online shops by attracting tech-savvy consumers looking for individualized hair loss solutions.
Country/Region-wise
The North American hair loss treatment products market is expanding rapidly, driven by rising demand for aesthetic treatments and increased awareness of innovative hair restoration options. According to latest market research data from March 2024, the market value hit USD 4.2 Billion in 2023 and is expected to increase at a CAGR of 9.8% between 2024 and 2028. This increase is most obvious in the United States, where roughly 50 million men and 30 million women suffer from hair loss, with 66% of males experiencing visible hair loss by the age of 35, according to the American Hair Loss Association's January 2024 report.
In August 2023, Johnson & Johnson's announced of their improved topical hair growth solution, which had an 85% success rate in clinical trials, and Merck received FDA clearance in February 2024 for a novel oral therapy for androgenetic alopecia. Additionally, in September 2023, the Canadian government announced a USD 50 Million investment in research funding for hair restoration technologies, with an emphasis on stem cell therapy and individualized treatment options. The advent of telemedicine services has also aided market growth, with companies such as Hims & Hers reporting a 120% increase in hair loss consultations in Q4 2023 over the previous year.
The Asia Pacific hair loss treatment products market is experiencing unprecedented expansion, driven by rising beauty consciousness and rising disposable income across the region. According to a Verified Market Research published the hair care market is predicted to rise at a CAGR of 5.60% to USD 129.63 Billion by 2031, from USD 83.83 Billion in 2023. China leads this expansion, accounting for 34% of the market, followed by Japan and South Korea. According to the Asian Dermatological Association's March 2024 report, 42% of men and 25% of women in metropolitan Asian areas suffer from premature hair loss, with a 73% increase in treatment-seeking behavior among people aged 25-40 over the last two years.
In February 2024, the Japanese government announced a historic USD 200 Million effort to promote research and development in hair restoration technology, while Singapore's Health Sciences Authority (HSA) gave fast-track approval status to three innovative hair loss therapies in March 2024. Alibaba, the Chinese e-commerce giant, reported that hair loss treatment product sales increased by 156% year on year during the 2024 Lunar New Year shopping festival, while Indian pharmaceutical company Sun Pharma announced in April 2024 that it would expand its hair care portfolio by acquiring a Korean hair technology startup for USD 180 Million.
The competitive landscape of the Hair Loss Treatment Products Market is characterized by the presence of various players offering a range of solutions, including prescription medications, over-the-counter treatments, and natural or herbal remedies. The market is increasingly driven by innovation, with companies focusing on developing new, advanced formulations like low-level laser therapy (LLLT) devices and stem cell treatments. Consumer preference for non-invasive and natural solutions is also shaping the market. Additionally, the rise of e-commerce platforms has intensified competition, as brands target a global audience through online sales channels, offering customized treatment plans and subscription-based services.
Some of the prominent players operating in the hair loss treatment products market Include:
L'Oreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang
In July 2024, L'Oreal has launched a new plant-based, eco-friendly hair serum as part of its sustainability effort. The serum, which is part of the Kerastase line, targets early-stage hair thinning and is likely to appeal to environmentally aware consumers.
In June 2024, RepliCel announced development in its dermal sheath cup cell treatment for hair restoration. Early clinical data suggest enhanced hair follicle regeneration, and expanded trials are scheduled for late 2024.
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang